Bonesupport Holding AB (publ) (BONEX.ST)

244,40 +1,80 (+0,74%) Al cierre: 05:29PM CEST

Bonesupport Holding AB (publ)

Scheelevägen 19
Lund 223 70
Sweden
46 4 62 86 53 70
https://www.bonesupport.com

Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 121

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Emil Billbäck	Chief Executive Officer	9,68M	N/A	1970
Mr. Håkan Johansson	Chief Financial Officer	248k	N/A	1963
Mr. Michael Wrang Mortensen	Executive Vice President of Global R&D and Operations	N/A	N/A	1975
Ms. Annelie Aava Vikner	Executive Vice President of Global Marketing	N/A	N/A	1971
Ms. Helena L. Brandt	Executive Vice President of Human Resources	N/A	N/A	1965
Dr. Michael Diefenbeck M.D., Ph.D.	Executive VP of Medical & Clinical Affairs and Chief Medical Officer	N/A	N/A	1974
Mr. Fergus MacLeod	GM & Executive VP of Commercial Operations of EUROW	N/A	N/A	1970
Mr. Michael Roth	GM & Executive VP of Commercial Operations of North America	N/A	N/A	1963

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en SEK.

Descripción

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. The company was founded in 1999 and is headquartered in Lund, Sweden.

Gobierno corporativo

El ISS Governance QualityScore de Bonesupport Holding AB (publ), a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.